Webinar: Accelerating Protein Analysis Throughput at Boehringer Ingelheim

Unlike traditional drug discovery, which focuses on inhibiting or activating proteins, targeted protein degradation (TPD) offers a more precise and efficient way to alter cellular pathways. However, TPD faces several challenges that need to be overcome to reach its full potential, including reducing the bottleneck of quantitative protein analysis.

In this upcoming webinar, the team at Boehringer Ingelheim present their recent real- world TPD project examples and in-depth analysis, covering insights on device and consumable management and optimized assay setups to increase protein analysis throughput.

Speakers

Andrea Stingu
Lab Scientist at Boehringer Ingelheim

Andrea started in the beginning of 2020 as a master student at Boehringer Ingelheim in the Department of Cancer Cell Signaling. After obtaining her Master, she continued to work at BI as a passionate lab scientist. Her interests lie particularly in validating new targets as well as testing and implementing novel techniques. Simple Western protein analysis has so far assisted her in making crucial project decisions whether it was checking protein expression, protein stability or the effect of compounds. In her spare time Andrea enjoys cooking and baking for her friends, dancing and handcrafting.

Johannes Wachter
MTA/ Technician at Boehringer Ingelheim

After finishing his master’s degree in molecular biology at the University of Vienna with a master’s thesis at Boehringer Ingelheim, Johannes took the opportunity to become full time employee at BI and to keep working in drug development. Starting in immune oncology he ended up working in cancer research five years ago where Johannes made his first experiences with protein analysis using the Wes system. Apart from working at research within BI he enjoys spending time with his family and friends playing board and card games or being outside hiking, playing basketball or volleyball.

Teresa Puchner
MTA/ Technician at Boehringer Ingelheim

Teresa is very much into bouldering, cycling and science. After finishing her master thesis at BI, she traveled south-east Asia, returned to BI and it has been more than five years since then. Protein analysis in the context of drug development was always a major part of her work and she enjoys communicating new Wes/Jess possibilities to the respective users to drive efficiency in research.